NCT06380361Completed
InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology
Source: ClinicalTrials.gov · Last updated 21 Apr 2026
Brief summary (registry, in English)
The objective of the study is to evaluate the feasibility of the BioSpy System sensor to differentiate tissues that are encountered during bronchoscopic biopsy of endobronchial tumors and peripheral lung nodules and masses.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 27 Mar 2024
- Start date
- 28 Mar 2024
- Primary completion date
- 23 Apr 2025
- Lead sponsor
- Sensome
- Diseases
- Lung cancer
- NCT number
- NCT06380361
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 28 Mar 2024 to the primary completion date, 23 Apr 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Target lesion \<10 mm for central and \<20 mm for peripheral lesions (as determined on previous imaging)
Other
- Contra-indication to bronchoscopy procedures
- Contra-indication to general anesthesia
- Any subject that is, according to the discretion of the investigator, not eligible for study participation
- Known lactating or confirmation of positive pregnancy test according to site specific standard of care (e.g. test, verbal communication)
Who the study is looking for
- Age \> 18 years
- Subjects with lesions eligible for lung biopsy under general anesthesia.
- Lesion localization:
- Central or proximal lesions ≥ 10 mm in diameter confirmed by imaging (CT scan and/or PET scan) and/or endobronchial visual control; or
- Peripheral lesions ≥ 20 mm in diameter confirmed by imaging (CT scan and/or PET scan) and/or ultrasound analysis (RP EBUS with central localization of the ultrasound probe) during the procedure.
- Written Informed Consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Brisbane and Women's Hospital Coordinator of this site? Confirm its status | Brisbane | Australia | Unknown status |
| Marie-Lannelongue Hospital Coordinator of this site? Confirm its status | Le Plessis-Robinson | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.